TPT 0501
Alternative Names: TPT-0501Latest Information Update: 11 Sep 2024
At a glance
- Originator Tetra Pharm Technologies
- Class Antidepressants
- Mechanism of Action Fatty acid amide hydrolase inhibitors; Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Depressive disorders
Most Recent Events
- 14 Aug 2024 Preclinical trials in Depressive disorders in Denmark (unspecified route) (Tetra Pharm Technologies pipeline, August 2024)